Purevax RC

10 x 1 dose
Lyophilisate and solvent for suspension for injection
SC

Species

Cats

Indications

Active immunisation of cats aged 8 weeks and older:

- against feline viral rhinotracheitis to reduce clinical signs, 

- against calicivirus infection to reduce clinical signs.

Onset of immunity: 1 week after primary vaccination course.

Duration of immunity: 1 year after primary vaccination course and 3 years after the last re-vaccination.

Dose to be administered and administration route

Subcutaneous route.

Reconstitute gently the vaccine in order to obtain a uniform suspension with limited foam formation.

Visual appearance after reconstitution: clear slightly yellow suspension.

After reconstitution of the lyophilisate with 0.5 ml or 1 ml of the solvent (depending on the presentation chosen) inject one dose of vaccine according to the following vaccination scheme:

Primary vaccination course:

- first injection: from 8 weeks of age, 

- second injection: 3 to 4 weeks later.

Where high levels of maternal antibodies against rhinotracheitis or calicivirosis components are expected to be present (e.g. in kittens of 9 to 12 weeks of age born from queens, which were vaccinated before pregnancy and/or with known or suspected previous exposure to the pathogen(s)), the primary vaccination course should be delayed until 12 weeks of age.

Revaccination:

- the first revaccination must be carried out one year after the primary vaccination course,

- subsequent revaccinations: at intervals of up to three years.

Adverse reactions

Cats:

Common

(1 to 10 animals / 100 animals treated):

Apathy, anorexia, and hyperthermia1 Injection site reactions (pain, itching, oedema)2.

Uncommon

(1 to 10 animals / 1,000 animals treated):

Hypersensitivity reaction3

Very rare

(<1 animal / 10,000 animals treated, including isolated reports):

Emesis4

1 lasting usually for 1 or 2 days.

2 slight pain at palpation, itching or limited oedema disappearing within 1 or 2 weeks at most.

3 may require appropriate symptomatic treatment.4 mostly within 24 to 48 hours.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See section “Contact details” of the package leaflet.

References

Leaflet is unavailable
Cat
PRICE Only for registered vets. Create a free profile to access all features.. Login
Art. Nr. 04491/5052
EAN 4028691579359
PACKAGES
Purevax RC
Boehringer Ingelheim Animal Health
10 x 1 dose
04491/5052
Purevax RC
Boehringer Ingelheim Animal Health
10 x 1 dose
04491/5052
VETiSearch ApS - C.F. Richs Vej 99D - 2000 Copenhagen - Denmark - contact@vetisearch.co.uk - Legal registration number: 39926679
VETiSearch.co.uk Copyright © 2025 . All rights reserved. This information is intended only for residents of Great Britain. The product information provided on this site is intended only for residents of Great Britain. Products may have different product information in different countries.